secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001437749-25-002273
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta recasts historical financials to reflect B Medical Systems as discontinued operations held for sale
--------------------------------------------------------------------------------

- For FY2024 (12 months ended Sep 30, 2024), continuing ops revenue $573.2M, operating loss $50.6M.
- Discontinued ops (B Medical) posted net loss of $140.5M for FY2024, classified as held for sale since Nov 12, 2024.
- Recast data covers multiple prior periods to help investors isolate core Sample Management & Multiomics segments.
- Sale of B Medical is intended to simplify portfolio and focus on core revenue growth and profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000143774925002273/0001437749-25-002273-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000143774925002273/azta20250124_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-002273

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer